Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hazard Ratio
100%
Prognostic Impact
100%
Acute Coronary Syndrome
100%
Inflammatory Markers
100%
Clopidogrel
100%
Ticagrelor
100%
Cardiovascular Mortality
60%
White Blood Cell Count
60%
Clinical Outcomes
40%
Interleukin-6
40%
Cardiovascular Effects
40%
C-reactive Protein
40%
Neutrophil Count
40%
Plato
40%
Pathophysiology
20%
High Risk
20%
Blood Samples
20%
Interleukin-10
20%
Coronary Artery Disease
20%
Myocardial Infarction
20%
Inflammation
20%
Plasma Parameters
20%
Adverse Cardiovascular Events
20%
Clinical Characteristics
20%
Troponin
20%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
20%
Invasive Procedures
20%
Absolute Risk Reduction
20%
Random Assignment
20%
Cystatin C (Cys C)
20%
Monocyte Count
20%
Differential White Blood Cell
20%
Continuous Model
20%
Immunology and Microbiology
Interleukin 6
100%
Leukocyte Count
100%
C-Reactive Protein
100%
Neutrophil Count
100%
Carboxy Terminal Sequence
50%
Amino Terminal Sequence
50%
Interleukin 10
50%
Blood Level
50%
Coronary Artery
50%
Leukocyte Differential Count
50%
Monocyte Count
50%
Troponin
50%
Natriuretic Peptide
50%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
100%
Clopidogrel
100%
Ticagrelor
100%
Interleukin 6
40%
C Reactive Protein
40%
Interleukin 10
20%
Heart Infarction
20%
Inflammation
20%
Coronary Artery Disease
20%
Pathophysiology
20%
Natriuretic Factor
20%
Troponin
20%
Cystatin C
20%
Biochemistry, Genetics and Molecular Biology
Clopidogrel
100%
Interleukin 6
40%
C-Reactive Protein
40%
Leukocyte Count
40%
Neutrophil Count
40%
C-Terminus
20%
N-Terminus
20%
Interleukin 10
20%
Blood Level
20%
Troponin
20%
Risk Reduction
20%
Natriuretic Peptide
20%
Cystatin C
20%
Leukocyte Differential Count
20%
Monocyte Count
20%